Sanjeevani – A Shot of Life: Network18 and Federal Bank's drive to raise awareness about COVID-19 vaccination

The initiative is a Federal Bank CSR drive that intends to reach every Indian with relevant and important information about the COVID-19 vaccine.

FP Staff April 07, 2021 09:34:15 IST
Sanjeevani – A Shot of Life: Network18 and Federal Bank's drive to raise awareness about COVID-19 vaccination

Representational image. AFP

On the occasion of World Health Day, Network18 will launch its latest ‘Sanjeevani – A Shot Of Life’ campaign on April 7. The campaign is aimed at creating and increasing awareness about vaccination against COVID-19 and why it is important to get inoculated.

The initiative is a Federal Bank CSR drive that intends to reach every Indian with relevant and important information about the COVID-19 vaccine.

With the launch of the COVID-19 vaccines, it is time to ensure every Indian gets the ‘Shot of Life’.

While India initially achieved praise for its quick response to COVID-19 and leading the push for the development of effective vaccines, the fast mutating virus and the slow pace of vaccination has pushed the nation into the grip of a second wave.

While there is no nationwide lockdown and economic activities continue to regain momentum, the situation remains grim. New restrictions have been imposed in nearly every state as new hotspots emerge.

The campaign has a three-point agenda: to spread awareness regarding vaccination and vaccines among all Indians, adopt villages and carry out vaccination drives targeting the lower strata of the society and creating awareness among masses and the social services sector about the initiative.

It is incumbent on corporates, non-governmental organisations and hospitals to help ensure that vaccines become popular, cheap and easily accessible. Thus, Network18 aims to take the onus and ensure that every Indian gets the COVID-19 jab and India returns to the "normal" soon.

While the government is hoping to inoculate as many people as possible, quickly, there are two major challenges: vaccine hesitancy and the cost.

Around 66 percent of India’s population lives in villages which are remote and inaccessible, making it necessary for us to ensure that every Indian gets vaccinated and the country returns to “normal”. While the COVID-19 jab may cost Rs 250, it is still an unaffordable price for large families.

The initiative’s launch event will happen at the Attari border near Amritsar, Punjab with on-ground and live attendance from guests including Union Health Minister Dr. Harsh Vardhan, Punjab Chief Minister Captain Amarinder Singh, AIIMS Director Randeep Guleria, Serum Institute of India’s CEO Adar Poonawala, Narayana Health’s chairperson Devi Shetty, NITI Aayog CEO Amitabh Kant, Punjab Health Minister Balbir Singh Sidhu, Border Security Force (BSF) DG Rakesh Asthana and CNN’s Chief Medical Correspondent Dr. Sanjay Gupta.

Additionally, the ‘Sanjeevani Gaadi’, which will be unveiled by Federal Bank’s MD and CEO Shyam Srinivasan, will be flagged off from the Attari border. The vehicle will travel across the country – including locations like Nashik, Guntur, Indore and Dakshina Kannada – spreading information about COVID-19 vaccines and busting myths. Apollo Hospitals is the "health expert" for the campaign and will help organise vaccination camps across the country over the course of the campaign.

Actor and philanthropist Sonu Sood is the campaign’s brand ambassador. You can check out the campaign video he shared on his Facebook page here.

Updated Date:

also read

10 crore people administered precaution dose against COVID-19: Health Minister Mansukh Mandaviya
India

10 crore people administered precaution dose against COVID-19: Health Minister Mansukh Mandaviya

The government had on 15 July launched a special 75-day special drive to administer precaution doses to all aged 18 years and above at public vaccination centres free of cost

Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin
India

Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

It was found in a study that tested immunogenicity and safety of booster dose of Corbevax that it can induce significant increase in antibody titers when given to those who have received either Covaxin or Covishield

Omicron, sub-lineages dominant COVID-19 variant in India; samples of infectious BA.2.75 also found: INSACOG
India

Omicron, sub-lineages dominant COVID-19 variant in India; samples of infectious BA.2.75 also found: INSACOG

In its 11 July bulletin, which was released Monday, INSACOG said the spread and frequency of BA.2.75 sub-variant is being closely monitored in every state